Latest News

Although Upper tract urothelial cancer (UTUC) is relatively rare in Western countries, it accounts for about 20-30% of all urothelial cancers in Taiwan.1,2 This unusually high incidence of UTUC led the Taiwan Urological Association to establish the Taiwan Upper Tract Urothelial Cancer Collaboration Group with the aim of performing a retrospective nationwide survey of all […]

Overactive bladder (OAB) is considered a lower urinary tract symptom (LUTS), affecting a patient’s quality of life. One of the most widely accepted theories explaining the pathophysiology of OAB is the irregular stimulation of sensory pathways and detrusor overactivity. This causes bladder hypersensitivity at low urine volumes (urinary urgency; UU). Our recent cross-sectional study demonstrated […]

New dates have been announced for urologists who would like to participate in the annual Global Prevalence Study on Infections in Urology (GPIU Study). Qualified urologists and urology departments collaborating with microbiologists and infectious disease specialists are encouraged to join. Their departments can participate on 9-11, 16-18 or 23-25 February 2022. Organisers emphasise the importance […]

To develop a nomogram to predict cancer-specific survival (CSS) in patients with metastatic testicular germ cell tumors (mTGCTs). Data were obtained from the Surveillance, Epidemiology, and End Results database.

Metastatic renal cell cancer (mRCC) management has undergone a paradigm shift in recent decades. The first revolution came with the emergence of vascular endothelial growth factor inhibitors; there was a second wave with the unprecedented success of checkpoint inhibitors, and then the latest approach, which is becoming the new care standard in mRCC, of combining […]

To determine the cost-effectiveness of annual renal imaging surveillance (RIS) in hereditary leiomyomatosis and renal cell cancer (HLRCC). HLRCC is associated with a 21% risk to age 70 years of RCC.

Black men have the highest incidence and mortality from prostate cancer (PCa) and lower quality of life compared to other U.S. racial groups. Additionally, more Latinx men are diagnosed with advanced disease and fewer receive guideline-concordant care.

Magnetic resonance guided radiotherapy (MRgRT), enabled by the clinical introduction of the integrated MRI and linear accelerator (MR-LINAC), is a novel technique for prostate cancer (PCa) treatment, promising to further improve clinical outcome and reduce toxicity.

Transrectal ultrasound (TRUS) guided biopsy for prostate cancer is prone to random and systemic error and has been shown to have a negative predictive value of 70%. PRECISION and PRECISE are among the first randomised studies to evaluate the new MRI-targeted biopsy (MRI-TB) pathway with a non-paired design to detect clinically significant prostate cancer and […]

Prostate tumor volume predicts biochemical recurrence, metastases, and tumor proliferation. A recent study showed that prostate tumor eccentricity (elongation or roundness) correlated with Gleason score.